徐聪聪
时间:2019-12-26

徐聪聪,博士,苏州大学国际创新药学院青年特聘教授。上海市白玉兰计划浦江人才。湖南大学化学学士学位,俄亥俄州立大学药学院获药剂科学博士学位(导师:郭培宣教授),2020-2023年于mRNA头部企业担任mRNA平台研发负责人,2023年受聘为苏州大学国际创新药学院青年特聘教授。现主持一项上海市科技创新行动计划项目及苏州大学高层次人才科研启动项目,以共同作者在Nature, ACS Nano, Molecular Therapy等国际期刊发表论文近二十余篇,获得国际专利授权两项,主要研究方向为新型RNA疫苗和药物。

论文:

nFan T#, Xu C# (co-first   author), Wu J#, Cai Y, Cao W, Shen H, Zhang M, Zhu H,   Yang J, Zhu Z, Ma X, Ren J, Huang L, Li Q, Tang Y, Yu B, Chen C, Xu M, Wang   Q, Xu Z, Chen F, Liang S, Zhong Z, Jamroze A, Tang DG, Li H, Dong C.   Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific   T cell responses and antitumor activity. Sci Adv. 2024 Oct   11;10(41):eadn9961. doi: 10.1126/sciadv.adn9961.

nCui G, Shao Y, Wang J, Xu C*, Jinping   Zhang*, Zhiyuan Zhong*, Polymersome-mediated Cbl-b silencing activates T   cells against solid tumors. Biomater.   Sci., 2025, doi:10.1039/D5BM00001G

nXu C, Yin H, Yudhistira T, Li Z, Binzel D,*Guo P*, Conversion of Chemical   Drugs into Targeting Ligands on RNA Nanoparticles and Assessing Payload   Stoichiometry for Optimal Biodistribution in Cancer Treatment. RNA   NanoMed, 2024, (1) 109-123.doi:10.59566/ISRNN.2024.0101109.

nXu, C., Zhang, L., Wang, W., Tang, Y.,   Wang, Q., An, J., ... & Li, H. (2023). Improving the Circularization   Efficiency, Stability and Translatability of Circular RNA by   circDesign. bioRxiv, 2023-07.

nZhang, H.,   Zhang, L., Lin, A.,Xu,   C. (co-first author), Li, Z., Liu,   K., ... & Huang, L. (2023). Algorithm for optimized mRNA design improves   stability and immunogenicity. Nature, 1-3.

[Commented on Nature news & views: Blakney, Anna   K. A tool for optimizing messenger RNA sequence. Nature (2023).;  Dolgin, Elie. 'Remarkable'AI tool designs mRNA vaccines that are more potent   and stable. Nature (2023).]

nCarcache PJ, Guo S, Li H, Zhang   K, Xu C, Chiu W, Guo P. Regulation of reversible conformational   change, size switching, and immunomodulation of RNA nanocubes. RNA.   2021 Sep 1;27(9):971-80.

nGuo S., Xu C., Yin H.,   Hill J., Pi F., Guo P. (2019). Tuning the size, shape and structure of RNA   nanoparticles for favorable cancer targeting and immunostimulation. WIREs   Nanomedicine and Nanobiotechnology, 2019 Aug 27:e1582. doi: 10.1002/wnan.1582.

nXu, C., Zhang, K., Yin, H., Li, Z.,   Krasnoslobodtsev, A., Zheng, Z., Ji, Z., Guo, S., Li, S., Chiu, W. and Guo,   P., 2020. 3D RNA nanocage for encapsulation and shielding of hydrophobic   biomolecules to improve the in vivo biodistribution. Nano Research,   13(12), pp.3241-3247.

nGhimire C, Wang H, Li H, Vieweger   M, Xu C, Guo P. RNA nanoparticles as rubber for compelling vessel   extravasation to enhance tumor targeting and for fast renal excretion to   reduce toxicity. ACS Nano. 2020 Sep 9;14(10):13180-91.

nZheng Z, Li Z, Xu C, Guo   B, Guo P. Folate-displaying exosome mediated cytosolic delivery of siRNA   avoiding endosome trapping. J Control Release. 2019Aug  22;. doi: 10.1016/j.jconrel.2019.08.021.

nYinH, Xiong G, Guo   S, XuC, Xu R,GuoP, Shu D. Delivery of Anti-miRNA for   Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem   Cell Marker CD133. Mol Ther. 2019 Jul 3;27(7):1252-1261.   doi: 10.1016/j.ymthe.2019.04.018.

nXu Y, Pang L, Wang H, Xu C,   Shah H, Guo P, Shu D, Qian SY. Specific delivery of delta-5-desaturase siRNA   via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon   cancer suppression. Redox Biol. 2019 Feb;21:101085. doi:   10.1016/j.redox.2018.101085.

nXu C, Li H, Zhang K, Binzel DW, Yin H,   Chiu W, Guo P. Photo-controlled release of paclitaxel and model drugs from   RNA pyramids. Nano Res. 2019 Jan;12(1):41-48. doi:   10.1007/s12274-018-2174-x.

nXu C, Haque F, Jasinski DL, Binzel DW,   Shu D, Guo P. Favorable biodistribution, specific targeting and conditional   endosomal escape of RNA nanoparticles in cancer therapy. Cancer   Lett. 2018 Feb 1;414:57-70. doi: 10.1016/j.canlet.2017.09.043.

nHaque F, Xu   C, Jasinski DL, Li H, Guo P. (Contributed   equally) Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape   of RNA Nanoparticles for Biodistribution Profiling in Mice. Methods   Mol Biol. 2017;1632:359-380. doi: 10.1007/978-1-4939-7138-1_23.

nGuo S, Xu C, Yin H, Guo   P, Hill J, and Pi F. 2022. Tuning the Size, Shape, and Structure of RNA   Nanoparticles for Favorable Cancer Targeting and Immunostimulation. RNA   Nanotechnology and Therapeutics, pp.543-562.